Veracyte
VCYT
61 hedge funds and large institutions have $73.5M invested in Veracyte in 2015 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 25 increasing their positions, 17 reducing their positions, and 5 closing their positions.
47% more repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 17
20% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 5
2% more funds holding
Funds holding: 60 → 61 (+1)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
57% less capital invested
Capital invested by funds: $172M → $73.5M (-$98.6M)
Top Buyers
Top Sellers
VCYT Hedge Fund Activity: Q3 2015 in Review
61 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Veracyte (VCYT) for Q3 2015, worth a combined $73.5M — down 57% from $172M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new VCYT positions and 5 closed out — a net gain of 1 holder — while 25 added to existing stakes and 17 trimmed.
The largest buyer was Driehaus Capital Management, opening a new position worth an estimated $2.3M. The largest seller was Camber Capital Management, cutting an estimated $3.02M.
- 61 institutional investors held Veracyte (VCYT) as of Q3 2015, up from 60 in Q2 2015.
- Funds reported $73.5M of Veracyte stock for Q3 2015, down 57% quarter-over-quarter.
- 6 funds opened new Veracyte positions in Q3 2015 and 5 closed out, a net change of +1 holder.
- The largest Veracyte buyer in Q3 2015 was Driehaus Capital Management, an estimated $2.3M added.
- The largest Veracyte seller in Q3 2015 was Camber Capital Management, an estimated $3.02M sold.
Based on aggregated 13F filings for Q3 2015.